Aristotle Atlantic Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $66.5M | Buy |
552,486
+55,876
| +11% | +$6.45M | 3.11% | 7 |
|
|
2025
Q4 | $52.3M | Hold |
496,610
| – | – | 2.39% | 10 |
|
|
2025
Q3 | $41.7M | Hold |
496,610
| – | – | 1.21% | 22 |
|
|
2025
Q2 | $39.3M | Hold |
496,610
| – | – | 1.2% | 24 |
|
|
2025
Q1 | $44.6M | Hold |
496,610
| – | – | 1.5% | 17 |
|
|
2024
Q4 | $49.4M | Hold |
496,610
| – | – | 1.55% | 17 |
|
|
2024
Q3 | $56.4M | Hold |
496,610
| – | – | 1.75% | 15 |
|
|
2024
Q2 | $61.5M | Sell |
496,610
-4,000
| -0.8% | -$515K | 1.99% | 13 |
|
|
2024
Q1 | $66.1M | Sell |
500,610
-17,000
| -3% | -$2.1M | 2.16% | 12 |
|
|
2023
Q4 | $56.4M | Hold |
517,610
| – | – | 1.99% | 15 |
|
|
2023
Q3 | $53.3M | Sell |
517,610
-9,200
| -2% | -$992K | 2.13% | 9 |
|
|
2023
Q2 | $60.8M | Hold |
526,810
| – | – | 2.29% | 7 |
|
|
2023
Q1 | $56M | Hold |
526,810
| – | – | 2.88% | 7 |
|
|
2022
Q4 | $58.4M | Hold |
526,810
| – | – | 3.27% | 6 |
|
|
2022
Q3 | $45.4M | Hold |
526,810
| – | – | 2.76% | 8 |
|
|
2022
Q2 | $48M | Sell |
526,810
-500
| -0.1% | -$44.3K | 3.69% | 6 |
|
|
2022
Q1 | $43.3M | Hold |
527,310
| – | – | 2.68% | 7 |
|
|
2021
Q4 | $40.4M | Sell |
527,310
-50,900
| -9% | -$4.05M | 2.35% | 11 |
|
|
2021
Q3 | $43.4M | Hold |
578,210
| – | – | 2.87% | 9 |
|
|
2021
Q2 | $45M | Sell |
578,210
-27,754
| -5% | -$2.06M | 2.97% | 8 |
|
|
2021
Q1 | $44.6M | Hold |
605,964
| – | – | 3.26% | 6 |
|
|
2020
Q4 | $47.3M | Sell |
605,964
-1,153
| -0.2% | -$88.2K | 3.65% | 5 |
|
|
2020
Q3 | $48.1M | Sell |
607,117
-29,029
| -5% | -$2.27M | 4.23% | 3 |
|
|
2020
Q2 | $46.9M | Hold |
636,146
| – | – | 4.51% | 4 |
|
|
2020
Q1 | $46.7M | Sell |
636,146
-47,160
| -7% | -$3.71M | 7.13% | 2 |
|
|
2019
Q4 | $59.3M | Hold |
683,306
| – | – | 7.57% | 1 |
|
|
2019
Q3 | $54.9M | Sell |
683,306
-12,576
| -2% | -$1.01M | 15.81% | 1 |
|
|
2019
Q2 | $55.7M | Sell |
695,882
-7,336
| -1% | -$562K | 16.19% | 1 |
|
|
2019
Q1 | $55.8M | Sell |
703,218
-10,480
| -1% | -$784K | 16.96% | 1 |
|
|
2018
Q4 | $52M | Hold |
713,698
| – | – | 18.34% | 1 |
|
|
2018
Q3 | $10.3M | Sell |
713,698
-14,672
| -2% | -$935K | 6.28% | 3 |
|
|
2018
Q2 | $42.2M | Hold |
728,370
| – | – | 14.63% | 1 |
|
|
2018
Q1 | $37.9M | Sell |
728,370
-40,010
| -5% | -$2.16M | 13.66% | 1 |
|
|
2017
Q4 | $41.3M | Buy |
+768,380
| New | +$42.6M | 14.81% | 1 |
|
Other funds holding MRK
VCM
VPM
Aristotle Atlantic Partners's MRK Position: Q1 2026 in Review
Aristotle Atlantic Partners increased its Merck (MRK) stake by 11% in Q1 2026, buying an estimated $6.45M and bringing the position to 552,486 shares worth $66.5M. The position accounts for 3.11% of the portfolio, ranked #7.
Aristotle Atlantic Partners first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Aristotle Atlantic Partners held 552,486 shares of Merck worth $66.5M as of Q1 2026.
- Aristotle Atlantic Partners bought 55,876 Merck shares in Q1 2026, an estimated $6.45M.
- Merck made up 3.11% of Aristotle Atlantic Partners's portfolio in Q1 2026, its #7 holding.
- Aristotle Atlantic Partners first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Aristotle Atlantic Partners's 13F filing for Q1 2026, filed 15 May 2026.